Cengild Medical Berhad (0243) — Capital Reinvestment Ratio
Latest as of December 2025:
39.05x
Cengild Medical Berhad (0243) has a Capital Reinvestment Ratio of 39.05x as of December 2025, meaning it reinvests 39% of its operating cash flow (RM947.00K) in capital expenditures (RM36.98 Million). See 0243 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
39.05x
Capex / Operating Cash Flow
Operating Cash Flow
RM947.00K
MYR
Capital Expenditures
RM36.98 Million
MYR
Data as of
Dec 2025
Most recent filing
Cengild Medical Berhad Capital Reinvestment Ratio (2020–2025)
This chart tracks Cengild Medical Berhad's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Cengild Medical Berhad (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cengild Medical Berhad from 2020 to 2025. For live market cap and broader valuation context, see Cengild Medical Berhad market capitalisation.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.32x | RM16.08 Million | RM37.26 Million | ▲ +90.5% |
| 2024 | 1.22x | RM12.94 Million | RM15.73 Million | ▲ +686.2% |
| 2023 | 0.15x | RM13.76 Million | RM2.13 Million | ▲ +408.4% |
| 2022 | 0.03x | RM14.05 Million | RM427.67K | ▼ -74.4% |
| 2021 | 0.12x | RM14.30 Million | RM1.70 Million | ▲ +118.8% |
| 2020 | 0.05x | RM11.24 Million | RM610.08K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow